N N Incl : Incl: Incl: Cannot be submitted A Commercialization E NIH, V 1.1 Plan R41, UT1, R43, for SBIR or STTR Plan should not be CDC, (NIH) Attachment U43 Phase I. submitted for Phase I FDA, applications. AHRQ, VA Incl : Incl: N N Incl: Required for Phase II, The E NIH, V 1.1 Plan R42, UT2, R44, Direct Phase II and Commercialization CDC, (NIH) Attachment U44, SB1, UB1 Fast Track Plan is required for FDA, submissions Phase II and Fast AHRQ, Track submissions. VA N N Incl : Incl: Incl: Limited to 12 pages The E NIH, V 1.1 Plan R42, UT2, R44, Commercialization CDC, (NIH) Attachment U44, SB1,UB1 Plan is limited to FDA, twelve (12) pages. AHRQ, VA Question 8. 023.14 Receipt of (NIH) Phase II SBIR Awards (Y/N) Company 023.15 (NIH) History Attachment Question 9. 023.16 SBIR PD/PI (NIH) Primary
(NIH) Plan Attachment N N Incl : NIH, CDC, FDA, AHRQ, VA Incl: V 1.1 Incl: R41, UT1, R43, U43 Cannot be submitted for SBIR or STTR Phase I. A Commercialization Plan should not be submitted for Phase I applications. E (NIH) Plan Attachment N N Incl : NIH, CDC, FDA, AHRQ, VA Incl: V 1.1 Incl: R42, UT2, R44, U44, SB1, UB1 Required for Phase II, Direct Phase II and Fast Track submissions The Commercialization Plan is required for Phase II and Fast Track submissions. E (NIH) Plan Attachment N N Incl : NIH, CDC, FDA, AHRQ, VA Incl: V 1.1 Incl: R42, UT2, R44, U44, SB1,UB1 Limited to 12 pages The Commercialization Plan is limited to twelve (12) pages. E (NIH) Question 8. Receipt of Phase II SBIR Awards (Y/N) 023.14 (NIH) Company History Attachment 023.15 (NIH) Question 9. SBIR PD/PI Primary 023.16